Skip to main content
OpenTrials
Completed

NCT Number: NCT02296385

Genotype-related Effects of PUFA

To assess the bioefficacy of omega-3 fatty acids (provided by intake of fish oil supplements) depending on genotype of relevant factors in lipid metabolism

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

To assess the bioefficacy of omega-3 fatty acids (provided by intake of fish oil supplements) depending on genotype of relevant factors in lipid metabolism.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy adult between 18 and 40 years of age
  • BMI between 18.5 and 30 kg/m2
  • Sedentary to moderate physical activity habits

Exclusion criteria

  • Concomitant treatment: Consumption of dietary supplements or any medication that can affect the study outcomes
  • Actively smoking
  • Suspected abuse of alcohol or illicit drugs
  • Significant illness within the two weeks prior to study start or any active systemic infection or medical condition that may require treatment during the study
  • Known or suspected medical condition related to coagulation
  • Subject who cannot be expected to comply with the study procedures
  • Currently participating or having participated in another clinical trial during the last 4 weeks prior to beginning of this study

Treatment and study plan

Triple Strength Fish Oil

Dietary Supplement

Triple Strength Fish Oil

Primary outcomes

  1. Changes in triglyceride levels in plasma

    Time frame: Baseline and 6 weeks intervention

Secondary outcomes

  1. Assess bioefficacy of EPA and DHA supplementation

    Time frame: Baseline and 6 weeks intervention

    The bioefficacy will be evaluated by characterizing and measuring the effects on lipid metabolism, glucose metabolism and insulin resistance, and inflammatory response

Sponsors and collaborators

Lead sponsor

Société des Produits Nestlé (SPN)

Industry

Registry information

Official study title

Response to PUFA Intervention According to PPAR Genotypes

Important dates

Study start
2012
Primary completion
2014
Study completion
2014
First posted
Nov 20, 2014
Registry last updated
Nov 20, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.